Thomas J. Shaw Buys 20,111 Shares of Retractable Technologies, Inc. (NYSE:RVP) Stock

Retractable Technologies, Inc. (NYSE:RVPGet Free Report) CEO Thomas J. Shaw bought 20,111 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were purchased at an average price of $0.62 per share, with a total value of $12,468.82. Following the transaction, the chief executive officer now owns 14,875,244 shares of the company’s stock, valued at $9,222,651.28. The trade was a 0.14 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Retractable Technologies Price Performance

Shares of NYSE:RVP opened at $0.63 on Wednesday. The company has a 50 day moving average of $0.71 and a 200-day moving average of $0.92. Retractable Technologies, Inc. has a one year low of $0.56 and a one year high of $1.34. The stock has a market cap of $18.84 million, a price-to-earnings ratio of -1.16 and a beta of 1.98. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Retractable Technologies in a research report on Wednesday, November 27th. They issued a “hold” rating for the company.

View Our Latest Stock Report on RVP

Institutional Trading of Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new position in shares of Retractable Technologies, Inc. (NYSE:RVPFree Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is owned by institutional investors and hedge funds.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Featured Articles

Insider Buying and Selling by Quarter for Retractable Technologies (NYSE:RVP)

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.